Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2020

Every FDA drug recall initiated in 2020, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

930 recalls, newest first.

Class II · Moderate risk

Estriol 8 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1421-2020
Class II · Moderate risk

Estriol 6 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1420-2020
Class II · Moderate risk

D-Biotin 300 mg Capsule

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1419-2020
Class II · Moderate risk

Lidothol Patch

CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.

Terminated cGMP deviation Preferred Pharmaceuticals, Inc. D-1390-2020
Class II · Moderate risk

Carbamazepine 200 mg Tablets

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Terminated Dissolution failure RemedyRepack Inc. NDC 70518-2489-00 D-1387-2020
Class III · Low risk

Tecfidera (dimethyl fumarate)

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Terminated cGMP deviation Biogen MA Inc. NDC 64406-006-02 D-1381-2020
Class III · Low risk

Nystatin Oral Suspension

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Terminated Impurity / degradation VistaPharm, Inc. NDC 66689-008-16 D-1378-2020
Class III · Low risk

Nystatin Oral Suspension

Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

Terminated Impurity / degradation VistaPharm, Inc. NDC 66689-037-50 D-1377-2020
Class I · High risk

Herbzeedy

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1482-2020
Class I · High risk

Goodness Gurus

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1481-2020
Class I · High risk

Goodness Gurus

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1480-2020
Class I · High risk

BC Hemp Co.

Chemical contamination: product contains elevated levels of undeclared lead.

Completed Chemical / undeclared Michigan Herbal Remedies D-1479-2020

Recalls by year